Alessandro Pastore

9.2k total citations
33 papers, 885 citations indexed

About

Alessandro Pastore is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Alessandro Pastore has authored 33 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pathology and Forensic Medicine and 8 papers in Hematology. Recurrent topics in Alessandro Pastore's work include Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (7 papers) and Ubiquitin and proteasome pathways (7 papers). Alessandro Pastore is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (7 papers) and Ubiquitin and proteasome pathways (7 papers). Alessandro Pastore collaborates with scholars based in Germany, United States and Italy. Alessandro Pastore's co-authors include Wolfgang Hiddemann, Omar Abdel‐Wahab, Martin Dreyling, Young Rock Chung, Malte Rieken, Oliver Weigert, Yvonne Zimmermann, Benjamin H. Durham, Grit Hutter and Elvira Mass and has published in prestigious journals such as Nature, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Alessandro Pastore

33 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Pastore Germany 16 384 259 195 182 179 33 885
R Espinosa United States 12 578 1.5× 242 0.9× 192 1.0× 208 1.1× 172 1.0× 15 1.0k
Patrik Georgii‐Hemming Sweden 14 409 1.1× 233 0.9× 90 0.5× 244 1.3× 68 0.4× 17 778
Malwina Suszyńska United States 20 567 1.5× 229 0.9× 59 0.3× 152 0.8× 192 1.1× 42 1.1k
Rob Dee Netherlands 9 400 1.0× 480 1.9× 102 0.5× 116 0.6× 221 1.2× 11 961
Carin Lassen Sweden 21 642 1.7× 570 2.2× 101 0.5× 180 1.0× 297 1.7× 35 1.3k
Marc Shuman United States 11 396 1.0× 126 0.5× 317 1.6× 186 1.0× 259 1.4× 20 1.1k
Robert Bayer United States 17 131 0.3× 215 0.8× 144 0.7× 262 1.4× 130 0.7× 23 754
M Schena Italy 17 245 0.6× 114 0.4× 142 0.7× 225 1.2× 287 1.6× 34 893
Frédéric Mourcin France 17 298 0.8× 151 0.6× 179 0.9× 315 1.7× 172 1.0× 31 1.2k
Seval Türkmen Germany 17 752 2.0× 276 1.1× 44 0.2× 147 0.8× 157 0.9× 36 1.3k

Countries citing papers authored by Alessandro Pastore

Since Specialization
Citations

This map shows the geographic impact of Alessandro Pastore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Pastore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Pastore more than expected).

Fields of papers citing papers by Alessandro Pastore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Pastore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Pastore. The network helps show where Alessandro Pastore may publish in the future.

Co-authorship network of co-authors of Alessandro Pastore

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Pastore. A scholar is included among the top collaborators of Alessandro Pastore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Pastore. Alessandro Pastore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chia‐Chi, Giuseppe Curigliano, Armando Santoro, et al.. (2024). Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study. BMJ Open. 14(8). e079132–e079132. 8 indexed citations
2.
Alig, Stefan, Vindi Jurinović, Alessandro Pastore, et al.. (2019). Impact of age on clinical risk scores in follicular lymphoma. Blood Advances. 3(7). 1033–1038. 15 indexed citations
3.
Hellmuth, Johannes C., Abner Louissaint, Monika Szczepanowski, et al.. (2018). Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. Blood. 132(16). 1695–1702. 42 indexed citations
4.
Nagase, Reina, Daichi Inoue, Alessandro Pastore, et al.. (2018). Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation. The Journal of Experimental Medicine. 215(6). 1729–1747. 110 indexed citations
5.
Mass, Elvira, Christian E. Jacome-Galarza, Thomas Blank, et al.. (2017). A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease. Experimental Hematology. 53. S79–S79. 11 indexed citations
6.
Pastore, Alessandro, Daichi Inoue, Nicolas Duployez, et al.. (2017). ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia. Nature Communications. 8(1). 15429–15429. 46 indexed citations
7.
Grommes, Christian, Alessandro Pastore, Igor T. Gavrilovic, et al.. (2016). Single-Agent Ibrutinib in Recurrent/Refractory Central Nervous System Lymphoma. Blood. 128(22). 783–783. 19 indexed citations
8.
Bararia, Deepak, Alessandro Pastore, German Ott, et al.. (2015). STAT6 Is Recurrently and Significantly Mutated in Follicular Lymphoma and Enhances the IL-4 Induced Expression of Membrane-Bound and Soluble CD23. Blood. 126(23). 3923–3923. 3 indexed citations
9.
10.
Hutter, Grit, Malte Rieken, Alessandro Pastore, et al.. (2012). The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma. Annals of Hematology. 91(6). 847–856. 28 indexed citations
11.
Savoia, Anna, Alessandro Pastore, Daniela De Rocco, et al.. (2010). Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. Haematologica. 96(3). 417–423. 70 indexed citations
12.
Hutter, Grit, Yvonne Zimmermann, Malte Rieken, et al.. (2010). Enzastaurin Treatment Affects Multiple Regulatory Pathways at Transcriptome and Cellular Proteome Level of Mantle Cell Lymphoma. Blood. 116(21). 2893–2893. 1 indexed citations
13.
Zimmermann, Yvonne, Elena Hartmann, Andreas Rosenwald, et al.. (2009). 2‐D PAGE‐based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma. Electrophoresis. 30(6). 974–986. 17 indexed citations
14.
Deshpande, Anagha, Alessandro Pastore, Aniruddha J. Deshpande, et al.. (2009). 3’UTR mediated regulation of the cyclin D1 proto-oncogene. Cell Cycle. 8(21). 3592–3600. 67 indexed citations
15.
Weigert, Oliver, Alessandro Pastore, Malte Rieken, et al.. (2007). Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma. Leukemia. 21(3). 524–528. 47 indexed citations
18.
McKay, James, Deborah J. Thompson, Fabienne Lesueur, et al.. (2004). Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. Journal of Medical Genetics. 41(6). 407–412. 39 indexed citations
19.
Stankov, Karmen, Alessandro Pastore, Luca Toschi, et al.. (2004). Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. International Journal of Cancer. 111(3). 463–467. 25 indexed citations
20.
D’Alfonso, Sandra, Marta Mellai, Mara Giordano, et al.. (2002). Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene and study of their association with multiple sclerosis. Journal of Neuroimmunology. 126(1-2). 196–204. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026